Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Angelica sinensis polysaccharide ameliorates myocardial ischemia-reperfusion injury in rats by inhibiting TLR4/NF-κB

Jianhua Ye, Shenghui Shen, Xialing Dai, Tianjie Zhang

Department of Cardiology, Tongde Hospital of Zhejiang Province, No. 234, Gucui Road, Xihu District, Hangzhou, Zhejiang 310012, China;

For correspondence:- Tianjie Zhang Email: ztj0011td@163.com

Accepted: 30 March 2023 Published: 29 April 2023

Citation: Ye J, Shen S, Dai X, Zhang T. Angelica sinensis polysaccharide ameliorates myocardial ischemia-reperfusion injury in rats by inhibiting TLR4/NF-κB. Trop J Pharm Res 2023; 22(4):777-782 doi: 10.4314/tjpr.v22i4.9

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To evaluate the ameliorative effect of Angelica sinensis polysaccharide (ASP) in myocardial ischemia-reperfusion injury (MIRI) rats through Toll-like receptor 4 (TLR4)/Nuclear factor κB (NF-κB) pathway.

Methods: The MIRI rat model was established. Sprague-Dawley rats were randomized to sham, MIRI, and ASP low-dose (50 mg/kg) and high-dose (100 mg/kg) groups, and a model of hypoxia-reoxygenation (H/R) injury was established. In in vitro studies, H/R cardiomycetes (derived from neonatal cell culture) were randomized to control, H/R, H/R + ASP low dose (5 μg/mL), H/R + ASP high dose (10 μg/mL), and ASP high dose + TLR4 activator groups.

Results: After intragastric administration of ASP for 4 consecutive weeks, creatine kinase isoenzyme (CK-MB) and lactate dehydrogenase (LDH) were reduced after ASP treatment in MIRI rats (p < 0.05). Both in vivo and in vitro, ASP reduced TNF-α, IL-6, and IL-1β expressions (p < 0.05), and alleviated inflammatory response. Apoptosis was inhibited by ASP, which also increased Bcl2, reduced Bax and cleaved caspase-3 expressions, while TLR-4, p-IκBα, and p-p65 were decreased.

Conclusion: The cardioprotective effect of ASP on MIRI results in the inhibition of TLR4/NF-κB pathway. Thus, this study broadens the current body of knowledge on the pharmacological prevention of MIRI and the therapeutic potential of ASP.

Keywords: Myocardial ischemia-reperfusion injury, Angelica sinensis polysaccharide, TLR4/NF-κB, Inflammation, Apoptosis